ALS News Today Spotlights Cognixion’s Clinical Trial for Non-Invasive BCI Headset
ALS News Today recently featured Cognixion in an article titled “Cognixion Seeks ALS Patients for Clinical Trial of BCI Headset”. The piece highlights our efforts to recruit participants living with ALS for a clinical study of our non-invasive brain-computer interface (BCI) headset, Cognixion ONE Axon.
This study represents a major step forward in our mission to deliver accessible communication technology to people with severe motor and speech impairments — and to validate it in partnership with the ALS community.
What the Study Involves
Our FDA Breakthrough Device–designated Cognixion ONE is a wearable headset that uses EEG brain signals, eye-tracking, augmented reality, and AI-assisted communication tools to enable users to speak and interact — even when traditional access methods are no longer possible.
This upcoming clinical trial will evaluate:
The headset’s usability and comfort
Its effectiveness in supporting communication
The experience of individuals with ALS and related motor disabilities
“We’re focused on building technology that empowers people with ALS to express themselves independently — no surgery required.”
— Andreas Forsland, CEO & Founder of Cognixion
Why It Matters.
As ALS News Today reports, people with ALS often experience a progressive loss of motor and speech function. Existing communication devices may become too difficult to use over time, leaving individuals isolated.
Our headset was designed specifically to address that challenge — offering a hands-free, voice-free, surgery-free path to communication, built with direct feedback from individuals affected by ALS and their caregivers.
By participating in this study, individuals can help shape the next generation of non-invasive assistive technology — technology that could soon be available for real-world use in clinics, care facilities, and homes.
How to Get Involved
If you or someone you know is living with ALS and interested in participating, we encourage you to learn more:
🔗 Read the full article:
ALS News Today – Cognixion Seeks ALS Patients for Clinical Trial
📩 Learn more about the study or express interest:
https://clinicaltrials.gov/study/NCT06810219